ICD-10 Code C81.34 | Lymphocy deplet Hdgkn lymph, nodes of axla and upr lmb Symptoms, Diagnosis, Billing

Lymphocyte depletion in the Hodgkin's lymphoma affecting the lymph nodes of the axilla and upper limb is a critical condition that indicates a significant reduction in lymphocyte count due to malignancy. This condition is clinically important as it can lead to immunosuppression and increased susceptibility to infections. The ICD-10 Code C81.34 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.

What is ICD-10 Code C81.34 for Lymphocy deplet Hdgkn lymph, nodes of axla and upr lmb?

ICD-10 Code C81.34 represents lymphocyte depletion in Hodgkin's lymphoma specifically affecting the lymph nodes of the axilla and upper limb. This code is used when documenting cases of Hodgkin's lymphoma that exhibit significant lymphocyte reduction, which may complicate the patient's clinical picture. It is essential for accurate clinical documentation and billing, particularly in oncology and hematology settings.

ICD-10 Code C81.34 – Clinical Definition and Explanation of Lymphocy deplet Hdgkn lymph, nodes of axla and upr lmb

Lymphocyte depletion in Hodgkin's lymphoma affecting the axillary and upper limb lymph nodes is primarily caused by the malignant proliferation of Reed-Sternberg cells, leading to a reduction in normal lymphocyte populations. This condition can progress to severe immunosuppression, necessitating prompt medical attention.

Key Clinical Features:

• Presence of enlarged lymph nodes in the axilla and upper limb.
• Symptoms may include fever, night sweats, and weight loss.
• Laboratory findings show reduced lymphocyte counts.
• Potential for secondary infections due to immunosuppression.

ICD-10 Code C81.34 for Lymphocy deplet Hdgkn lymph, nodes of axla and upr lmb – SOAP Notes & Clinical Use

ICD-10 Code C81.34 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to lymphocyte depletion in Hodgkin's lymphoma. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code C81.34 for Lymphocy deplet Hdgkn lymph, nodes of axla and upr lmb Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C81.34 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of lymphocyte depletion in Hodgkin's lymphoma. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C81.34 – Lymphocy deplet Hdgkn lymph, nodes of axla and upr lmb

The management of lymphocyte depletion in Hodgkin's lymphoma requires urgent medical intervention, often necessitating hospitalization for intensive treatment.

Antibiotic Therapy:

• First-line: Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD regimen) for chemotherapy.
• Alternative: Escalated BEACOPP regimen for advanced stages.
• Duration: Typically 6-8 cycles depending on response.

Supportive Care:

• Monitor for signs of infection and provide prophylactic antibiotics.
• Administer growth factors to stimulate bone marrow recovery.
• Provide nutritional support and manage symptoms such as pain and fatigue.

Infection Control:

• Implement strict hand hygiene protocols.
• Isolate patients with febrile neutropenia.
• Educate patients on avoiding exposure to infectious agents.

How to Document Symptoms of Lymphocy deplet Hdgkn lymph, nodes of axla and upr lmb (ICD-10 C81.34) in SOAP Notes

Subjective:

• Patient reports persistent fatigue and unexplained weight loss.
• Complaints of night sweats and fever episodes.
• History of recurrent infections over the past few months.

Objective:

• Physical examination reveals enlarged axillary lymph nodes.
• Complete blood count shows lymphopenia.
• Imaging studies indicate lymphadenopathy in the upper limb.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Lymphocy deplet Hdgkn lymph, nodes of axla and upr lmb (ICD-10 Code C81.34)

Assessment:

• Diagnosis: Lymphocyte depletion due to Hodgkin's lymphoma, moderate severity.
• ICD-10 Subcode: C81.34.
• Contributing factors include advanced disease stage and immunosuppression.

Plan:

• Initiate chemotherapy with ABVD regimen.
• Educate patient on signs of infection and when to seek care.
• Schedule follow-up appointments for monitoring treatment response.

Treatment & Plan Section for ICD-10 Code C81.34 – Lymphocy deplet Hdgkn lymph, nodes of axla and upr lmb

• First-line pharmacologic treatment includes chemotherapy regimens such as ABVD.
• Non-pharmacologic strategies involve nutritional support and infection prevention measures.
• Monitoring includes regular CBC checks and imaging studies to assess treatment response.
• Follow-up practices should include scheduled oncology visits and symptom management.

Using ICD-10 Code C81.34 for Lymphocy deplet Hdgkn lymph, nodes of axla and upr lmb in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Commonly billed CPT codes include chemotherapy administration and imaging studies.

Related ICD-10 Codes Often Used with Lymphocy deplet Hdgkn lymph, nodes of axla and upr lmb

• C81.20 – Hodgkin lymphoma, lymph nodes of head, face, and neck
• C81.30 – Hodgkin lymphoma, lymph nodes of mediastinum

ICD-10 Code C81.34 in Medical Billing and Insurance for Lymphocy deplet Hdgkn lymph, nodes of axla and upr lmb

ICD-10 Code C81.34 is essential for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure documentation includes detailed patient history and clinical findings.
• Use this code in settings where chemotherapy or supportive care is provided.
• Highlight key chart elements such as lab results and treatment plans.

Common CPT Pairings: